Clinical trials
Active, not recruiting Phase 2 Adenocarcinoma of Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| M.D. Anderson Cancer Center | 1 |
| Pfizer | 1 |
| SOLTI Breast Cancer Research Group | 1 |
| SWOG Cancer Research Network | 1 |
| The First People's Hospital of Changzhou | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 8 |
| Lung Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Anus Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.